ArticleFrontiers in immunology2025

CD155-TIGIT/CD96/CD226 immune checkpoint axis interacting with tumor-infiltrating lymphocytes to exhibit diverse prognostic effects on breast cancer: a cohort study.

Xin Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.